KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Cme (CME) over the last 17 years, with Q3 2025 value amounting to -$2.6 billion.

  • Cme's Enterprise Value fell 557.02% to -$2.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 billion, marking a year-over-year decrease of 557.02%. This contributed to the annual value of -$3.0 billion for FY2024, which is 59.86% up from last year.
  • As of Q3 2025, Cme's Enterprise Value stood at -$2.6 billion, which was down 557.02% from -$2.1 billion recorded in Q2 2025.
  • Cme's Enterprise Value's 5-year high stood at -$1.0 billion during Q1 2021, with a 5-year trough of -$3.0 billion in Q4 2023.
  • Moreover, its 5-year median value for Enterprise Value was -$2.1 billion (2025), whereas its average is -$2.1 billion.
  • In the last 5 years, Cme's Enterprise Value crashed by 11263.81% in 2022 and then skyrocketed by 2250.73% in 2023.
  • Cme's Enterprise Value (Quarter) stood at -$2.9 billion in 2021, then grew by 4.54% to -$2.8 billion in 2022, then dropped by 7.37% to -$3.0 billion in 2023, then grew by 0.6% to -$3.0 billion in 2024, then grew by 14.49% to -$2.6 billion in 2025.
  • Its Enterprise Value stands at -$2.6 billion for Q3 2025, versus -$2.1 billion for Q2 2025 and -$1.5 billion for Q1 2025.